1-3 of 3
Eivind Coward, PhD
Close
Sort by
Journal Articles

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

Kristine Misund, PhD, Davine Hofste Op Bruinink, MD, Eivind Coward, PhD, Remco Hoogenboezem, MSc, Even H Rustad, MD, Eivind Hovig, PhD, Anders Sundan, PhD, Ola Myklebost, PhD, Pieter Sonneveld, MD PhD, Anders Waage, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3157.
https://doi.org/10.1182/blood-2018-99-113553
Published: 2018
Journal Articles

Detection and Monitoring of BRAF and NRAS Mutant Clones in Myeloma Patients By Digital PCR of Circulating DNA

Even Holth Rustad, Hong Yan Dai, PhD, Eivind Coward, PhD, Kristine Misund, PhD, Anders Sundan, PhD, Anders Waage, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4196.
https://doi.org/10.1182/blood.V126.23.4196.4196
Published: 2015
Journal Articles

Clinical and Biological Implications of BRAF V600E Mutation in Multiple Myeloma

Even Holth Rustad, Hong Yan Dai, PhD, Haakon Hov, MDPhD, Eivind Coward, PhD, Vidar Beisvag, PhD, Ola Myklebost, MDPhD, Eivind Hovig, PhD, Sigve Nakken, PhD, Daniel Vodák, Leonardo A Meza-Zepeda, PhD, Arne K Sandvik, MDPhD, Karin Fahl Wader, MD PhD, Kristine Misund, PhD, Anders Sundan, PhD, Harald Aarset, MDPhD, Anders Waage, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5685.
https://doi.org/10.1182/blood.V124.21.5685.5685
Published: 2014